{"ticker": {"uuid": "fe327179-0d58-4f4b-9f98-62b6a0a1e1ce", "symbol": "SMTI", "name": "Sanara Medtech Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Instruments & Supplies"}, "articles": [{"title": "Sanara MedTech Inc. (NASDAQ:SMTI) Receives Consensus Recommendation of \"Moderate Buy\" from Analysts", "summary": "Sanara MedTech Inc. (NASDAQ:SMTI) has received a consensus \"Moderate Buy\" rating from five brokerages, with an average 12-month price target of $34.00. While some analysts upgraded the stock, others remained cautious, resulting in a mixed but generally positive outlook. The compa", "url": "https://www.marketbeat.com/instant-alerts/sanara-medtech-inc-nasdaqsmti-receives-consensus-recommendation-of-moderate-buy-from-analysts-2026-07-13/", "source_name": "MarketBeat", "published_at": "2026-07-13T11:11:57", "published_display": "13 Jul 2026 11:11", "sentiment": "positive", "sentiment_pct": 70, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Trading Systems Reacting to (SMTI) Volatility", "summary": "Quantitative analysis of Sanara Medtech Inc. (SMTI) reveals mixed sentiment across different time horizons, suggesting choppy trading conditions. The analysis highlights no clear price positioning signal but indicates compelling upside potential with no resistance levels above th", "url": "https://news.stocktradersdaily.com/news_release/12/Trading_Systems_Reacting_to_SMTI_Volatility_071026013201_1783661521.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-10T01:32:00", "published_display": "10 Jul 2026 01:32", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech Inc outlines its wound care focus. Longer-term growth story draws investor interest", "summary": "Sanara MedTech Inc. (SMTI) operates in the U.S. wound care market, providing specialized products and services for hospitals and clinics. The company's growth strategy focuses on expanding its product portfolio, increasing distribution, and offering solutions for complex wounds. ", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/sanara-medtech-inc-outlines-its-wound-care-focus-longer-term-growth-story/69715295", "source_name": "AD HOC NEWS", "published_at": "2026-07-07T14:40:50", "published_display": "07 Jul 2026 14:40", "sentiment": "positive", "sentiment_pct": 77, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Sanara MedTech Inc. \u2013 NASDAQ:SMTI", "summary": "The article discusses the \"Price to book forward\" metric for Sanara MedTech Inc. (NASDAQ: SMTI) within the context of TradingView's financial data platform. It primarily functions as a navigation point to the company's financial overview, emphasizing the specific stock's listing ", "url": "https://www.tradingview.com/symbols/NASDAQ-SMTI/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T20:11:54", "published_display": "05 Jul 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Sanara MedTech Inc. \u2013 BOATS:SMTI", "summary": "This article provides the \"Price to sales forward\" financial metric for Sanara MedTech Inc. (SMTI), listed under the Blue Ocean Alternative Trade System (BOATS). It appears to be a stub or data point from TradingView, focusing on a single financial statistic for the company.", "url": "https://www.tradingview.com/symbols/BOATS-SMTI/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T20:11:54", "published_display": "05 Jul 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Sanara MedTech Inc. \u2013 NASDAQ:SMTI", "summary": "This article provides financial data for Sanara MedTech Inc. (SMTI) on TradingView, focusing specifically on its forward price-to-sales ratio. It presents a value for this metric over a given period, along with its change and percentage change.", "url": "https://www.tradingview.com/symbols/NASDAQ-SMTI/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T12:40:32", "published_display": "05 Jul 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Sanara MedTech Inc. \u2013 NASDAQ:SMTI", "summary": "This article focuses on the enterprise value to revenue forward metric for Sanara MedTech Inc. (NASDAQ: SMTI). It provides a high-level overview of this financial ratio for the company, indicating key data points like period, value, and change. The content appears to be a snapsho", "url": "https://www.tradingview.com/symbols/NASDAQ-SMTI/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-04T10:39:41", "published_display": "04 Jul 2026 10:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Sanara MedTech Inc. \u2013 BOATS:SMTI", "summary": "This article provides the \"Price to earnings forward\" metric for Sanara MedTech Inc. (SMTI) as traded on the Blue Ocean Alternative Trade System (BOATS). The content appears to be a financial data point from TradingView, indicating the value and change for this specific financial", "url": "https://www.tradingview.com/symbols/BOATS-SMTI/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-03T22:11:02", "published_display": "03 Jul 2026 22:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Sanara MedTech Inc. \u2013 NASDAQ:SMTI", "summary": "This article focuses on the enterprise value to EBITDA forward for Sanara MedTech Inc. (NASDAQ: SMTI). It provides a brief overview of the company's financial metric, presented through TradingView, and mentions the data sources for the information.", "url": "https://www.tradingview.com/symbols/NASDAQ-SMTI/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-03T16:10:13", "published_display": "03 Jul 2026 16:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech (SMTI) Surges 2.35% as Bulls Test Resistance at $26.08 - Change of Character", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNT2dMR1V0c3l3UHhhMlVSU2p3TFRVN1FqUUszdWNQU0tETTY5cnB1S0NmZl9aaGhiY2h0d1ZNamN6Zi1WSEZTR21QNVhIUWVZVWJWRU5iQ0ZQQ2NPaWxUUm5Qb29WV0VlaF9SaDJ5RUpRQ2ctOUtCbVdlcElKaWVoN0FFWTZ5VkotVDhsRzB1WGJFOTdoNENpZ1hqQ0VGV0VaQXJCMktjTEwtdDA?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-03T02:33:13+00:00", "published_display": "03 Jul 2026 02:33", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Sanara Medtech Inc. (SMTI) Affects Rotational Strategy Timing", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxNNFpvOGh6X3NJWTYzZTE3R2FMX2p1aE93OXVsVW5WMm40ak9wMjQ4b1lqNjkwSWJwRGZiQVVvRFlCNGZfNlUzSDFuZTllR1UtNzNKX3BySW9fR3dJV1lva3luaUw1Y0QyX3BHdlBvaHRuWFk2TzJIZjktejcyRXhCN21CRV83ZFhwajEyTVZ0bUtncVo1dlpuRF9Ca2NrcHl1MnYyUjAyMHZTYXFKT2RaUDBKdXdmenZhMTNwYU5UdHM3M3Exd3VOTVNDMEJpODJMbmlfdjJyTjZmUQ?oc=5", "source_name": "Stock Traders Daily", "published_at": "2026-06-29T00:24:02+00:00", "published_display": "29 Jun 2026 00:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech, Inc. Actuals & Estimates (NASDAQ:SMTI)", "summary": "This article provides key financial data and analyst estimates for Sanara MedTech Inc. (SMTI), a medical specialties company traded on NASDAQ. It covers stock performance, price forecasts, earnings, revenue, market capitalization, and volatility, highlighting a recent increase in", "url": "https://www.tradingview.com/symbols/NASDAQ-SMTI/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T06:40:52", "published_display": "26 Jun 2026 06:40", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara Medtech Inc (SMTI) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "Sanara Medtech Inc (SMTI) has an earnings forecast score of 8.00, ranking 56th in the Pharmaceuticals industry. Analysts have an average price target of $41.00 for SMTI, with a \"Buy\" rating based on 3 analysts. The company's expected revenue for the next quarter is $28.95 million", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-smti/earnings", "source_name": "TradingKey", "published_at": "2026-06-26T02:51:40", "published_display": "26 Jun 2026 02:51", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SMTI Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for Sanara MedTech Inc. (SMTI) stock based on analyst opinions. It includes current stock performance metrics, historical price data, financial figures like market capitalization, revenue, and earnings, as well as an upcoming earn", "url": "https://www.tradingview.com/symbols/NASDAQ-SMTI/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-25T12:11:40", "published_display": "25 Jun 2026 12:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech (SMTI) Stock Gets Fair Value Bump As Analysts Back Wound Care Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOMk8zVmJwMEtaMERFWUhlWW1NMXVWaTZib0lDMC1jV01XY3IwTGRtMGZsaFBJV3E2bXJmYlVNOG1wSGhla2NldTAwZUhQaE1VZFNGcmlrcEhXNmZEem9HeUN1aFdtVVNUY0VWRlZuZmxJY2xWakI0M3FTTDRtanpWaXdhLTNHeDktdk80Uk56RFM0Zk9rQUVUS0NUUQ?oc=5", "source_name": "Market source", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech (SMTI) Surges 3.77% as Shares Test Key Resistance - Earnings Miss Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPZHNsX0FVZlRJVzRWVTZ1TEpMS0tVZ0tjal9sWl8tXzdwcUNoRTlKc0JsTFp2WkZPdkF2UTAxcndGWmRKQUpWV1lCTDV1NmNyZTJPQTB4RG51NklqYW1iTTR1R1NrWl9RR0FxMHp5eDhwT2hqa0FCTFlueDAtREFobjVtZ1pOdmxNdzNENTZpY2JwZXR4eEJtRDNpa1MzNTBIOHYyNW85Qm8wMUk?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-06-21T07:00:00+00:00", "published_display": "21 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara Medtech Inc (SMTI) Financial Health: Profitability & Balance Sheet Analysis", "summary": "Sanara Medtech Inc (SMTI) has a stable financial status with a score of 7.31 out of 100, ranking 120th in the Pharmaceuticals industry. The company reported a significant year-over-year revenue increase of 18.62% to $27.80 million and a net profit increase of 113.01%. Key financi", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-smti/financial-health", "source_name": "TradingKey", "published_at": "2026-06-18T10:11:29", "published_display": "18 Jun 2026 10:11", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara Medtech Inc (SMTI) Institutional Confidence", "summary": "Sanara Medtech Inc (SMTI) currently holds an institutional shareholding score of 3.00, ranking 94th in the Pharmaceuticals industry. Institutional shareholding increased by 18.63% quarter-over-quarter, with 15.50% of the company's shares held by institutions. James Simons is note", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-smti/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T10:11:29", "published_display": "18 Jun 2026 10:11", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara Medtech Inc (SMTI) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "This article provides a risk assessment for Sanara Medtech Inc (SMTI), highlighting its current risk score of 2.90 and its ranking within the Pharmaceuticals industry. It details key metrics such as the company's beta value of 1.22, indicating higher volatility compared to the S&", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-smti/risk-assesment", "source_name": "TradingKey", "published_at": "2026-06-18T10:10:55", "published_display": "18 Jun 2026 10:10", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara Medtech Inc (SMTI) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a valuation analysis for Sanara Medtech Inc (SMTI), highlighting its current valuation score of 8.42, which ranks 96th out of 157 in the Pharmaceuticals industry. It details the company's P/E ratio of -5.45 and notes that relevant data for P/B, P/S, and P/CF", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-smti/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-18T10:10:54", "published_display": "18 Jun 2026 10:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara Medtech Inc (SMTI) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of Sanara Medtech Inc (SMTI) regarding its dividend history and stock splits. It explicitly states that there is no data available for past dividends or stock splits for the company over the last five years. The page also includes current stock i", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-smti/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T04:40:48", "published_display": "17 Jun 2026 04:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara Medtech Inc (SMTI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a detailed revenue breakdown for Sanara Medtech Inc (SMTI), highlighting its primary business segments. For the specified period, the company generated $91.35 million from soft tissue repair products, accounting for 88.59% of its revenue, and $11.77 million ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-smti/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T04:40:48", "published_display": "17 Jun 2026 04:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech (SMTI) investors approve board, auditor and 3-year say-on-pay cycle", "summary": "Sanara MedTech Inc. shareholders approved the election of nine directors, ratified Weaver and Tidwell, L.L.P. as their independent auditor for 2026, and gave advisory approval to executive officer compensation. In a separate advisory vote, shareholders favored holding future say-", "url": "https://www.stocktitan.net/sec-filings/SMTI/8-k-sanara-med-tech-inc-reports-material-event-001361903621.html", "source_name": "Stock Titan", "published_at": "2026-06-09T20:15:49", "published_display": "09 Jun 2026 20:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Restricted stock grant to Sanara MedTech (SMTI) director Eric D. Major", "summary": "Sanara MedTech (SMTI) director Eric D. Major was granted 4,846 shares of restricted common stock under the company\u2019s 2024 Omnibus Long-Term Incentive Plan, increasing his direct holdings to 14,232 shares. This grant was made at no cash cost and is considered an equity-based compe", "url": "https://www.stocktitan.net/sec-filings/SMTI/form-4-sanara-med-tech-inc-insider-trading-activity-9b3d4d9fd97c.html", "source_name": "Stock Titan", "published_at": "2026-06-06T07:39:58", "published_display": "06 Jun 2026 07:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] Sanara MedTech Inc. Insider Trading Activity", "summary": "Sanara MedTech Inc. director Eric D. Tanzberger reported an acquisition of 5,308 shares of common stock as restricted stock compensation, granted at $0.00 per share. Following this award, he directly holds 22,966 shares. The restricted stock will vest on the earlier of the 2027 a", "url": "https://www.stocktitan.net/sec-filings/SMTI/form-4-sanara-med-tech-inc-insider-trading-activity-09f27e457317.html", "source_name": "Stock Titan", "published_at": "2026-06-06T01:10:14", "published_display": "06 Jun 2026 01:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech (SMTI) director granted 4,616 restricted stock shares under 2024 plan", "summary": "Sanara MedTech director Sara N. Ortwein was granted 4,616 restricted shares of common stock under the company\u2019s 2024 Omnibus Long-Term Incentive Plan. These shares, awarded at no cash cost, increase her direct holdings to 25,415 shares and will vest on the earlier of the company\u2019", "url": "https://www.stocktitan.net/sec-filings/SMTI/form-4-sanara-med-tech-inc-insider-trading-activity-7f4803a21a83.html", "source_name": "Stock Titan", "published_at": "2026-06-06T01:10:14", "published_display": "06 Jun 2026 01:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech (SMTI) director awarded 5,308 restricted shares vesting in 2027", "summary": "Sanara MedTech Inc. (SMTI) director Mack Roszell III was granted 5,308 shares of restricted common stock as equity compensation, with a grant price of $0.00. These shares will vest on the earlier of the company's 2027 annual shareholder meeting or June 4, 2027, contingent on his ", "url": "https://www.stocktitan.net/sec-filings/SMTI/form-4-sanara-med-tech-inc-insider-trading-activity-2652c725f371.html", "source_name": "Stock Titan", "published_at": "2026-06-06T01:10:14", "published_display": "06 Jun 2026 01:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech (SMTI) director Ronald Nixon receives 4,154 restricted shares grant", "summary": "Sanara MedTech Inc. director Ronald T. Nixon was granted 4,154 restricted shares of common stock as equity compensation under the company's 2024 Omnibus Long-Term Incentive Plan. The shares will vest on the earlier of the 2027 annual shareholder meeting or June 4, 2027, contingen", "url": "https://www.stocktitan.net/sec-filings/SMTI/form-4-sanara-med-tech-inc-insider-trading-activity-5c75da8d9699.html", "source_name": "Stock Titan", "published_at": "2026-06-06T01:10:14", "published_display": "06 Jun 2026 01:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech (SMTI) Posts Modest Gain as Support Holds Steady - PCR Divergence", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPYm51U0lZWWFQeDlxOWNGUjEzTWFIMWhuUWJZZWMtMUgyNEZvRlFubDBjbW1kSjQ3MHUtcEVMak4tM0RNMHFMVG81QVdNUFNiX1ZSWGlTbWQ4QzIzUGVwRkEyQWV4X2U1bkxQSFkwNFhOX3ZfNktuMWJqbzFUT1VZVFdTLVQtaEJtVmxvRkR2RE5VY29TN1B6MWZyVjl1c0stXzV6UnBnQjc?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara Medtech Terminates Services Agreement With Catalyst Effective June 2", "summary": "Sanara Medtech announced the termination of its services agreement with Catalyst, effective June 2. This brief report, sourced from Reuters/Refinitiv, conveys key corporate action by Sanara Medtech. Investors interested in SMTI should note this development regarding the company's", "url": "https://www.tradingview.com/news/reuters.com,2026:newsml_FWN42C0NK:0-sanara-medtech-terminates-services-agreement-with-catalyst-effective-june-2/", "source_name": "TradingView", "published_at": "2026-06-04T20:41:06", "published_display": "04 Jun 2026 20:41", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech Ends Advisory Services Agreement With The Catalyst Group Amid Strategy Shift", "summary": "Sanara MedTech (SMTI) has terminated its Transaction Advisory Services Agreement with The Catalyst Group, effective June 2, 2026. This mutual termination aligns with Sanara MedTech's strategic decision to focus on soft tissue repair and bone fusion products for the surgical marke", "url": "https://www.tradingview.com/news/tradingview:67e219a029196:0-sanara-medtech-ends-advisory-services-agreement-with-the-catalyst-group-amid-strategy-shift/", "source_name": "TradingView", "published_at": "2026-06-04T20:41:05", "published_display": "04 Jun 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech (NASDAQ: SMTI) terminates Catalyst advisory agreement", "summary": "Sanara MedTech Inc. (NASDAQ: SMTI) has terminated its Transaction Advisory Services Agreement with The Catalyst Group, Inc., effective June 2, 2026. This decision aligns with Sanara MedTech's strategic shift to focus on soft tissue repair and bone fusion products for the surgical", "url": "https://www.stocktitan.net/sec-filings/SMTI/8-k-sanara-med-tech-inc-reports-material-event-0eacd9c27e9a.html", "source_name": "Stock Titan", "published_at": "2026-06-04T20:41:05", "published_display": "04 Jun 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SMTI - Sanara MedTech Inc Stock Price and Quote", "summary": "This page provides comprehensive stock information for Sanara MedTech Inc. (SMTI), including its last close price, financial overview, key ratios, performance metrics, and a detailed list of recent news and analyst actions. The company specializes in biotechnology products for me", "url": "https://finviz.com/stock?t=SMTI", "source_name": "Finviz", "published_at": "2026-06-02T18:40:13", "published_display": "02 Jun 2026 18:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech (SMTI) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/a8e4fc64-2cc2-373f-915d-2ba1c7219227/sanara-medtech-%28smti%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-06-02T16:56:58+00:00", "published_display": "02 Jun 2026 16:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Sanara MedTech (SMTI) Narrative Is Shifting As The US$34 Target Stays Put", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/sanara-medtech-smti-narrative-shifting-011451454.html", "source_name": "Simply Wall St.", "published_at": "2026-05-23T01:14:51+00:00", "published_display": "23 May 2026 01:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech: From Cash Burner To Profitable Growth (NASDAQ:SMTI)", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQSXhJaDcweE1oRUxOSnpRSTZIbzRhTWtBd3I3c0c5UEhSNmlSeDdOalhUNU41YjVaVjVhMVJEZWF3eDBhSEEtaGZKYUdSenVjYkpldHRnR2pPLXNMS2hRcGg2empqejRQUnVzWTBMYVdIU21rcFY1eGRSZDg0TzZ6YWF2UkUyVW5wWGhEWVlxUjlLYzdxTndiWHRzcm5mLUU5?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/7bedfbad-d0e8-38de-a9ff-4504197d029f/sanara-medtech-inc.-q1-2026.html", "source_name": "Moby", "published_at": "2026-05-13T12:30:00+00:00", "published_display": "13 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech Inc (SMTI) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ...", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/sanara-medtech-inc-smti-q1-190242219.html", "source_name": "GuruFocus.com", "published_at": "2026-05-12T19:02:42+00:00", "published_display": "12 May 2026 19:02", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech Inc (SMTI) Q1 2026 Earnings Report Preview: What To Expect", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/sanara-medtech-inc-smti-q1-132204062.html", "source_name": "GuruFocus.com", "published_at": "2026-05-11T13:22:04+00:00", "published_display": "11 May 2026 13:22", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUnBQaVJ0MWxxN1FlbWRacGpLY01PcW9hMGtnZ09Fd3drdmNicXZuQmI2S21sRnNORlBoT2EyeG9aTC00cGtYbVcxU2dGbzRjX1RvNWh2SkNrdGFJTHJLTERnZFdRREcxZmhRR0JHb3J4M0xMYlJMSWNmVFRJLXFKdldyaGxoN2x1ZHlYSU1sTWN5T3FYc0dsV1JwWXFQbVRGdkZ6aVh6V1k1RlR2QnBJMktOQTR1RVpmVGlsdzlGNnZ5dWwxSXFmcTh6M0YyZGRqN2RqWE81Q0Z6VmlfOXc?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Sanara MedTech (SMTI) Is Reframing Its Growth Story Around A Steady US$34 Target", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/sanara-medtech-smti-reframing-growth-131721941.html", "source_name": "Simply Wall St.", "published_at": "2026-05-05T13:17:21+00:00", "published_display": "05 May 2026 13:17", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What Makes Sanara Medtech (SMTI) A Compelling Risk-Reward Opportunity?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPdjMwWGxDNDVZNGtQSDNkdV9KSGFiUzlOZXNEV0pjVDNJS1dBUVZ5bFNWTEt3akYzay10bDFFQUhmRFVfS2Z0ckVXb0tnbEtJQzhVeUtLNmJYakgxdmxlNDZWZURtbWlLdDF6ek16UjIyYzNVZUl6cnJxOUR4NXVFVFFXWUl1RmxqSHB5Vk1Xby1MNjUzN1RheTJ1ckNVVGtON3pz?oc=5", "source_name": "Market source", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Sanara MedTech (SMTI) Story Is Shifting With New Targets And Growth Assumptions", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQaUp4M3ZuX3B1a0xmeGtQbWlJYWRvNm9sR29SYjFjWlZ1SlA1QWdMVWtGRXhwMVlKQllPVHRWNXlwSVJjNV9BMW05YWY5ZERrTGgzbVJmSkI2OGlaNW55X2dlZjBEdHY0dlJhbW81QVBsVEs2MTVNLV9WMTNlaWdJUDRwd1dKWE9YYVQyMkFZRVFpYnRtdmI2WTlkMHRjdkJn?oc=5", "source_name": "Market source", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech Inc. (SMTI) Q4 Earnings Miss Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQX29JZW1MX0pzNmY4TzNPQmFYOXB0MktaS09UY0JzWExqOTJ5MHM4QU5jeTFHTWRTT3NLeVh6OHpiNkdBM0QxYVMzTVQtMDc3endlcjBZa2hxa05Gcm1RV2VuUzZuNVVYZENER3M2dTV6enI3MndCNHNnYVU5U0llRHRnX1RGWGJFWE5PUXFCUEJ1Q1J2UGtkeFhzMA?oc=5", "source_name": "Market source", "published_at": "2026-03-24T07:00:00+00:00", "published_display": "24 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech (SMTI) Is Down 23.5% After Q3 Loss and THP Exit \u2013 Has the Investment Case Shifted?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxNbjRiM0NJMm9PNlhteEdreGxnM2RFMVRSdmdrd1NEVzNyeUVnWTUxYXhDbzN0U0NlUlBvcXBjWkRUUl9GQU1BUzAtMmxhT1Zad3dtUzdaSk9EM2h0anZvOGZHT3A4UGxuZ082c1NKM0ozWjJVN1lMZ3lnTjZ6UVhGa2drSmxKSnBlaldtVWwzRFBkZ1Z4bVZMd09VQU54VHdpY1ZXOGk1YmpfV25CMTNDSWJBQk5Ib2Y2bUZVdDV0bmZQLS1fQXVNeFZCQTZBdVhy0gHWAUFVX3lxTFBRZEMzOW5FM3JubldzVFlXZFNRbnVNZGdtR01mNk5Fakl0XzBZdHdxdC1OTGdFQUJMYnJrWml5elowSmJMZEdMSF9xWVdSNFN5Q290d05obmJadTd0UmR1NUJTUUR6SnNVZ1c2U0dXYkUxNklwWHp0THFQbXNwN0FBeVVsbnlDRHFJRVd4SHV0R0JDX1JyX2pOVEJvbVVHUXhUQmRUZnE1NDJ0OWdCUng0bUpVLWZaTWo2aDBJWkNXcFoxS1UxX2Q2cHlYelE2NTRBX05WTVE?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-13T08:00:00+00:00", "published_display": "13 Nov 2025 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech Inc. Completes Evaluation of Strategic Alternatives, Discontinues Tissue Health Plus Operations", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxQSU9XVUFuLWRmRG1ra0RzUkxEV2E0VEFoS25QM2xlSFJkMHlHak5sRG5LV3ktTmpZeG0yYlZqQXhUR0tlUjVKNl96YVF6NF9pdTA0b0NfdjZqd3dHZUI4aXdjMkFTd1VBRy1OWFl5bE1rTnNGNUVvbE1RV3RPV2otelJURnAzQkhwV0NEdng1ZGtBUEVhMUZOaTZrX01iNGYtS0NtZjNLOGNOVWtKcXNmcGtrWHRZZ0kyRTVmcHo5eTlTRDgwS25ITU9DZEY4YUNpNFlsT1ljYzBDZ1E?oc=5", "source_name": "Quiver Quantitative", "published_at": "2025-11-11T08:00:00+00:00", "published_display": "11 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The recent pullback must have dismayed Sanara MedTech Inc. (NASDAQ:SMTI) insiders who own 31% of the company", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-07-16T07:00:00+00:00", "published_display": "16 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech Inc. Announces Closing of Scendia Biologics, LLC Acquisition", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxPY2ljQnJOVUtrSGNlY243eEFXUUF4MkJidUNQWjN3SEl2TXlHeXN2OWJxVEdfU1hQMUZEY1Y0SzFUMG4zZnQ1SmNGRTVnVGo0UFpWZEh1WFJkNzZ2RzRnUWVCY1dPQ0ItVHNhZWloYWZMejlISTYyX3k1WExrLXN5UXd4QjllNXBtbjgzUmdKSDU4U3dPXzU4NE1lcGpKZGJEYTUxbjRxN1VtRzJNejJJaXcxaVpERDBzOVNxMjFic0RKdWdYdUI1dElsT2RBNk85LWozX0NSVElCcHlJRGc?oc=5", "source_name": "GlobeNewswire", "published_at": "2022-07-05T07:00:00+00:00", "published_display": "05 Jul 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech (SMTI) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE9qbE45TFRZaXdyQkdrcF9UMDVjdHBXanktTDNkcG1uQ3FTLVM2RTZwemlpYVl0VXZDd3NnWC1IRU45TDZ2bHAyWGFXRUNTTzF1TFJNUHpNY0hjUQ?oc=5", "source_name": "MarketBeat", "published_at": "2019-10-22T14:54:48+00:00", "published_display": "22 Oct 2019 14:54", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Sanara MedTech Inc. (NASDAQ:SMTI) Receives Consensus Recommendation of \"Moderate Buy\" from Analysts", "summary": "Sanara MedTech Inc. (NASDAQ:SMTI) has received a consensus \"Moderate Buy\" rating from five brokerages, with an average 12-month price target of $34.00. While some analysts upgraded the stock, others remained cautious, resulting in a mixed but generally positive outlook. The compa", "url": "https://www.marketbeat.com/instant-alerts/sanara-medtech-inc-nasdaqsmti-receives-consensus-recommendation-of-moderate-buy-from-analysts-2026-07-13/", "source_name": "MarketBeat", "published_at": "2026-07-13T11:11:57", "published_display": "13 Jul 2026 11:11", "sentiment": "positive", "sentiment_pct": 70, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Trading Systems Reacting to (SMTI) Volatility", "summary": "Quantitative analysis of Sanara Medtech Inc. (SMTI) reveals mixed sentiment across different time horizons, suggesting choppy trading conditions. The analysis highlights no clear price positioning signal but indicates compelling upside potential with no resistance levels above th", "url": "https://news.stocktradersdaily.com/news_release/12/Trading_Systems_Reacting_to_SMTI_Volatility_071026013201_1783661521.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-10T01:32:00", "published_display": "10 Jul 2026 01:32", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech Inc outlines its wound care focus. Longer-term growth story draws investor interest", "summary": "Sanara MedTech Inc. (SMTI) operates in the U.S. wound care market, providing specialized products and services for hospitals and clinics. The company's growth strategy focuses on expanding its product portfolio, increasing distribution, and offering solutions for complex wounds. ", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/sanara-medtech-inc-outlines-its-wound-care-focus-longer-term-growth-story/69715295", "source_name": "AD HOC NEWS", "published_at": "2026-07-07T14:40:50", "published_display": "07 Jul 2026 14:40", "sentiment": "positive", "sentiment_pct": 77, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Sanara MedTech Inc. \u2013 NASDAQ:SMTI", "summary": "The article discusses the \"Price to book forward\" metric for Sanara MedTech Inc. (NASDAQ: SMTI) within the context of TradingView's financial data platform. It primarily functions as a navigation point to the company's financial overview, emphasizing the specific stock's listing ", "url": "https://www.tradingview.com/symbols/NASDAQ-SMTI/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T20:11:54", "published_display": "05 Jul 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Sanara MedTech Inc. \u2013 BOATS:SMTI", "summary": "This article provides the \"Price to sales forward\" financial metric for Sanara MedTech Inc. (SMTI), listed under the Blue Ocean Alternative Trade System (BOATS). It appears to be a stub or data point from TradingView, focusing on a single financial statistic for the company.", "url": "https://www.tradingview.com/symbols/BOATS-SMTI/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T20:11:54", "published_display": "05 Jul 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Sanara MedTech Inc. \u2013 NASDAQ:SMTI", "summary": "This article provides financial data for Sanara MedTech Inc. (SMTI) on TradingView, focusing specifically on its forward price-to-sales ratio. It presents a value for this metric over a given period, along with its change and percentage change.", "url": "https://www.tradingview.com/symbols/NASDAQ-SMTI/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T12:40:32", "published_display": "05 Jul 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Sanara MedTech Inc. \u2013 NASDAQ:SMTI", "summary": "This article focuses on the enterprise value to revenue forward metric for Sanara MedTech Inc. (NASDAQ: SMTI). It provides a high-level overview of this financial ratio for the company, indicating key data points like period, value, and change. The content appears to be a snapsho", "url": "https://www.tradingview.com/symbols/NASDAQ-SMTI/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-04T10:39:41", "published_display": "04 Jul 2026 10:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Sanara MedTech Inc. \u2013 BOATS:SMTI", "summary": "This article provides the \"Price to earnings forward\" metric for Sanara MedTech Inc. (SMTI) as traded on the Blue Ocean Alternative Trade System (BOATS). The content appears to be a financial data point from TradingView, indicating the value and change for this specific financial", "url": "https://www.tradingview.com/symbols/BOATS-SMTI/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-03T22:11:02", "published_display": "03 Jul 2026 22:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Sanara MedTech Inc. \u2013 NASDAQ:SMTI", "summary": "This article focuses on the enterprise value to EBITDA forward for Sanara MedTech Inc. (NASDAQ: SMTI). It provides a brief overview of the company's financial metric, presented through TradingView, and mentions the data sources for the information.", "url": "https://www.tradingview.com/symbols/NASDAQ-SMTI/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-03T16:10:13", "published_display": "03 Jul 2026 16:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech (SMTI) Surges 2.35% as Bulls Test Resistance at $26.08 - Change of Character", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNT2dMR1V0c3l3UHhhMlVSU2p3TFRVN1FqUUszdWNQU0tETTY5cnB1S0NmZl9aaGhiY2h0d1ZNamN6Zi1WSEZTR21QNVhIUWVZVWJWRU5iQ0ZQQ2NPaWxUUm5Qb29WV0VlaF9SaDJ5RUpRQ2ctOUtCbVdlcElKaWVoN0FFWTZ5VkotVDhsRzB1WGJFOTdoNENpZ1hqQ0VGV0VaQXJCMktjTEwtdDA?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-03T02:33:13+00:00", "published_display": "03 Jul 2026 02:33", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Sanara Medtech Inc. (SMTI) Affects Rotational Strategy Timing", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxNNFpvOGh6X3NJWTYzZTE3R2FMX2p1aE93OXVsVW5WMm40ak9wMjQ4b1lqNjkwSWJwRGZiQVVvRFlCNGZfNlUzSDFuZTllR1UtNzNKX3BySW9fR3dJV1lva3luaUw1Y0QyX3BHdlBvaHRuWFk2TzJIZjktejcyRXhCN21CRV83ZFhwajEyTVZ0bUtncVo1dlpuRF9Ca2NrcHl1MnYyUjAyMHZTYXFKT2RaUDBKdXdmenZhMTNwYU5UdHM3M3Exd3VOTVNDMEJpODJMbmlfdjJyTjZmUQ?oc=5", "source_name": "Stock Traders Daily", "published_at": "2026-06-29T00:24:02+00:00", "published_display": "29 Jun 2026 00:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech, Inc. Actuals & Estimates (NASDAQ:SMTI)", "summary": "This article provides key financial data and analyst estimates for Sanara MedTech Inc. (SMTI), a medical specialties company traded on NASDAQ. It covers stock performance, price forecasts, earnings, revenue, market capitalization, and volatility, highlighting a recent increase in", "url": "https://www.tradingview.com/symbols/NASDAQ-SMTI/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T06:40:52", "published_display": "26 Jun 2026 06:40", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara Medtech Inc (SMTI) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "Sanara Medtech Inc (SMTI) has an earnings forecast score of 8.00, ranking 56th in the Pharmaceuticals industry. Analysts have an average price target of $41.00 for SMTI, with a \"Buy\" rating based on 3 analysts. The company's expected revenue for the next quarter is $28.95 million", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-smti/earnings", "source_name": "TradingKey", "published_at": "2026-06-26T02:51:40", "published_display": "26 Jun 2026 02:51", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SMTI Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for Sanara MedTech Inc. (SMTI) stock based on analyst opinions. It includes current stock performance metrics, historical price data, financial figures like market capitalization, revenue, and earnings, as well as an upcoming earn", "url": "https://www.tradingview.com/symbols/NASDAQ-SMTI/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-25T12:11:40", "published_display": "25 Jun 2026 12:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech (SMTI) Stock Gets Fair Value Bump As Analysts Back Wound Care Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOMk8zVmJwMEtaMERFWUhlWW1NMXVWaTZib0lDMC1jV01XY3IwTGRtMGZsaFBJV3E2bXJmYlVNOG1wSGhla2NldTAwZUhQaE1VZFNGcmlrcEhXNmZEem9HeUN1aFdtVVNUY0VWRlZuZmxJY2xWakI0M3FTTDRtanpWaXdhLTNHeDktdk80Uk56RFM0Zk9rQUVUS0NUUQ?oc=5", "source_name": "Market source", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech (SMTI) Surges 3.77% as Shares Test Key Resistance - Earnings Miss Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPZHNsX0FVZlRJVzRWVTZ1TEpMS0tVZ0tjal9sWl8tXzdwcUNoRTlKc0JsTFp2WkZPdkF2UTAxcndGWmRKQUpWV1lCTDV1NmNyZTJPQTB4RG51NklqYW1iTTR1R1NrWl9RR0FxMHp5eDhwT2hqa0FCTFlueDAtREFobjVtZ1pOdmxNdzNENTZpY2JwZXR4eEJtRDNpa1MzNTBIOHYyNW85Qm8wMUk?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-06-21T07:00:00+00:00", "published_display": "21 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara Medtech Inc (SMTI) Financial Health: Profitability & Balance Sheet Analysis", "summary": "Sanara Medtech Inc (SMTI) has a stable financial status with a score of 7.31 out of 100, ranking 120th in the Pharmaceuticals industry. The company reported a significant year-over-year revenue increase of 18.62% to $27.80 million and a net profit increase of 113.01%. Key financi", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-smti/financial-health", "source_name": "TradingKey", "published_at": "2026-06-18T10:11:29", "published_display": "18 Jun 2026 10:11", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara Medtech Inc (SMTI) Institutional Confidence", "summary": "Sanara Medtech Inc (SMTI) currently holds an institutional shareholding score of 3.00, ranking 94th in the Pharmaceuticals industry. Institutional shareholding increased by 18.63% quarter-over-quarter, with 15.50% of the company's shares held by institutions. James Simons is note", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-smti/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T10:11:29", "published_display": "18 Jun 2026 10:11", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara Medtech Inc (SMTI) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "This article provides a risk assessment for Sanara Medtech Inc (SMTI), highlighting its current risk score of 2.90 and its ranking within the Pharmaceuticals industry. It details key metrics such as the company's beta value of 1.22, indicating higher volatility compared to the S&", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-smti/risk-assesment", "source_name": "TradingKey", "published_at": "2026-06-18T10:10:55", "published_display": "18 Jun 2026 10:10", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara Medtech Inc (SMTI) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a valuation analysis for Sanara Medtech Inc (SMTI), highlighting its current valuation score of 8.42, which ranks 96th out of 157 in the Pharmaceuticals industry. It details the company's P/E ratio of -5.45 and notes that relevant data for P/B, P/S, and P/CF", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-smti/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-18T10:10:54", "published_display": "18 Jun 2026 10:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara Medtech Inc (SMTI) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of Sanara Medtech Inc (SMTI) regarding its dividend history and stock splits. It explicitly states that there is no data available for past dividends or stock splits for the company over the last five years. The page also includes current stock i", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-smti/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T04:40:48", "published_display": "17 Jun 2026 04:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara Medtech Inc (SMTI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a detailed revenue breakdown for Sanara Medtech Inc (SMTI), highlighting its primary business segments. For the specified period, the company generated $91.35 million from soft tissue repair products, accounting for 88.59% of its revenue, and $11.77 million ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-smti/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T04:40:48", "published_display": "17 Jun 2026 04:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech (SMTI) investors approve board, auditor and 3-year say-on-pay cycle", "summary": "Sanara MedTech Inc. shareholders approved the election of nine directors, ratified Weaver and Tidwell, L.L.P. as their independent auditor for 2026, and gave advisory approval to executive officer compensation. In a separate advisory vote, shareholders favored holding future say-", "url": "https://www.stocktitan.net/sec-filings/SMTI/8-k-sanara-med-tech-inc-reports-material-event-001361903621.html", "source_name": "Stock Titan", "published_at": "2026-06-09T20:15:49", "published_display": "09 Jun 2026 20:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Restricted stock grant to Sanara MedTech (SMTI) director Eric D. Major", "summary": "Sanara MedTech (SMTI) director Eric D. Major was granted 4,846 shares of restricted common stock under the company\u2019s 2024 Omnibus Long-Term Incentive Plan, increasing his direct holdings to 14,232 shares. This grant was made at no cash cost and is considered an equity-based compe", "url": "https://www.stocktitan.net/sec-filings/SMTI/form-4-sanara-med-tech-inc-insider-trading-activity-9b3d4d9fd97c.html", "source_name": "Stock Titan", "published_at": "2026-06-06T07:39:58", "published_display": "06 Jun 2026 07:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] Sanara MedTech Inc. Insider Trading Activity", "summary": "Sanara MedTech Inc. director Eric D. Tanzberger reported an acquisition of 5,308 shares of common stock as restricted stock compensation, granted at $0.00 per share. Following this award, he directly holds 22,966 shares. The restricted stock will vest on the earlier of the 2027 a", "url": "https://www.stocktitan.net/sec-filings/SMTI/form-4-sanara-med-tech-inc-insider-trading-activity-09f27e457317.html", "source_name": "Stock Titan", "published_at": "2026-06-06T01:10:14", "published_display": "06 Jun 2026 01:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech (SMTI) director granted 4,616 restricted stock shares under 2024 plan", "summary": "Sanara MedTech director Sara N. Ortwein was granted 4,616 restricted shares of common stock under the company\u2019s 2024 Omnibus Long-Term Incentive Plan. These shares, awarded at no cash cost, increase her direct holdings to 25,415 shares and will vest on the earlier of the company\u2019", "url": "https://www.stocktitan.net/sec-filings/SMTI/form-4-sanara-med-tech-inc-insider-trading-activity-7f4803a21a83.html", "source_name": "Stock Titan", "published_at": "2026-06-06T01:10:14", "published_display": "06 Jun 2026 01:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech (SMTI) director awarded 5,308 restricted shares vesting in 2027", "summary": "Sanara MedTech Inc. (SMTI) director Mack Roszell III was granted 5,308 shares of restricted common stock as equity compensation, with a grant price of $0.00. These shares will vest on the earlier of the company's 2027 annual shareholder meeting or June 4, 2027, contingent on his ", "url": "https://www.stocktitan.net/sec-filings/SMTI/form-4-sanara-med-tech-inc-insider-trading-activity-2652c725f371.html", "source_name": "Stock Titan", "published_at": "2026-06-06T01:10:14", "published_display": "06 Jun 2026 01:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech (SMTI) director Ronald Nixon receives 4,154 restricted shares grant", "summary": "Sanara MedTech Inc. director Ronald T. Nixon was granted 4,154 restricted shares of common stock as equity compensation under the company's 2024 Omnibus Long-Term Incentive Plan. The shares will vest on the earlier of the 2027 annual shareholder meeting or June 4, 2027, contingen", "url": "https://www.stocktitan.net/sec-filings/SMTI/form-4-sanara-med-tech-inc-insider-trading-activity-5c75da8d9699.html", "source_name": "Stock Titan", "published_at": "2026-06-06T01:10:14", "published_display": "06 Jun 2026 01:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech (SMTI) Posts Modest Gain as Support Holds Steady - PCR Divergence", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPYm51U0lZWWFQeDlxOWNGUjEzTWFIMWhuUWJZZWMtMUgyNEZvRlFubDBjbW1kSjQ3MHUtcEVMak4tM0RNMHFMVG81QVdNUFNiX1ZSWGlTbWQ4QzIzUGVwRkEyQWV4X2U1bkxQSFkwNFhOX3ZfNktuMWJqbzFUT1VZVFdTLVQtaEJtVmxvRkR2RE5VY29TN1B6MWZyVjl1c0stXzV6UnBnQjc?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara Medtech Terminates Services Agreement With Catalyst Effective June 2", "summary": "Sanara Medtech announced the termination of its services agreement with Catalyst, effective June 2. This brief report, sourced from Reuters/Refinitiv, conveys key corporate action by Sanara Medtech. Investors interested in SMTI should note this development regarding the company's", "url": "https://www.tradingview.com/news/reuters.com,2026:newsml_FWN42C0NK:0-sanara-medtech-terminates-services-agreement-with-catalyst-effective-june-2/", "source_name": "TradingView", "published_at": "2026-06-04T20:41:06", "published_display": "04 Jun 2026 20:41", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech Ends Advisory Services Agreement With The Catalyst Group Amid Strategy Shift", "summary": "Sanara MedTech (SMTI) has terminated its Transaction Advisory Services Agreement with The Catalyst Group, effective June 2, 2026. This mutual termination aligns with Sanara MedTech's strategic decision to focus on soft tissue repair and bone fusion products for the surgical marke", "url": "https://www.tradingview.com/news/tradingview:67e219a029196:0-sanara-medtech-ends-advisory-services-agreement-with-the-catalyst-group-amid-strategy-shift/", "source_name": "TradingView", "published_at": "2026-06-04T20:41:05", "published_display": "04 Jun 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech (NASDAQ: SMTI) terminates Catalyst advisory agreement", "summary": "Sanara MedTech Inc. (NASDAQ: SMTI) has terminated its Transaction Advisory Services Agreement with The Catalyst Group, Inc., effective June 2, 2026. This decision aligns with Sanara MedTech's strategic shift to focus on soft tissue repair and bone fusion products for the surgical", "url": "https://www.stocktitan.net/sec-filings/SMTI/8-k-sanara-med-tech-inc-reports-material-event-0eacd9c27e9a.html", "source_name": "Stock Titan", "published_at": "2026-06-04T20:41:05", "published_display": "04 Jun 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SMTI - Sanara MedTech Inc Stock Price and Quote", "summary": "This page provides comprehensive stock information for Sanara MedTech Inc. (SMTI), including its last close price, financial overview, key ratios, performance metrics, and a detailed list of recent news and analyst actions. The company specializes in biotechnology products for me", "url": "https://finviz.com/stock?t=SMTI", "source_name": "Finviz", "published_at": "2026-06-02T18:40:13", "published_display": "02 Jun 2026 18:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech (SMTI) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/a8e4fc64-2cc2-373f-915d-2ba1c7219227/sanara-medtech-%28smti%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-06-02T16:56:58+00:00", "published_display": "02 Jun 2026 16:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Sanara MedTech (SMTI) Narrative Is Shifting As The US$34 Target Stays Put", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/sanara-medtech-smti-narrative-shifting-011451454.html", "source_name": "Simply Wall St.", "published_at": "2026-05-23T01:14:51+00:00", "published_display": "23 May 2026 01:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech: From Cash Burner To Profitable Growth (NASDAQ:SMTI)", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQSXhJaDcweE1oRUxOSnpRSTZIbzRhTWtBd3I3c0c5UEhSNmlSeDdOalhUNU41YjVaVjVhMVJEZWF3eDBhSEEtaGZKYUdSenVjYkpldHRnR2pPLXNMS2hRcGg2empqejRQUnVzWTBMYVdIU21rcFY1eGRSZDg0TzZ6YWF2UkUyVW5wWGhEWVlxUjlLYzdxTndiWHRzcm5mLUU5?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/7bedfbad-d0e8-38de-a9ff-4504197d029f/sanara-medtech-inc.-q1-2026.html", "source_name": "Moby", "published_at": "2026-05-13T12:30:00+00:00", "published_display": "13 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech Inc (SMTI) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ...", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/sanara-medtech-inc-smti-q1-190242219.html", "source_name": "GuruFocus.com", "published_at": "2026-05-12T19:02:42+00:00", "published_display": "12 May 2026 19:02", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech Inc (SMTI) Q1 2026 Earnings Report Preview: What To Expect", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/sanara-medtech-inc-smti-q1-132204062.html", "source_name": "GuruFocus.com", "published_at": "2026-05-11T13:22:04+00:00", "published_display": "11 May 2026 13:22", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUnBQaVJ0MWxxN1FlbWRacGpLY01PcW9hMGtnZ09Fd3drdmNicXZuQmI2S21sRnNORlBoT2EyeG9aTC00cGtYbVcxU2dGbzRjX1RvNWh2SkNrdGFJTHJLTERnZFdRREcxZmhRR0JHb3J4M0xMYlJMSWNmVFRJLXFKdldyaGxoN2x1ZHlYSU1sTWN5T3FYc0dsV1JwWXFQbVRGdkZ6aVh6V1k1RlR2QnBJMktOQTR1RVpmVGlsdzlGNnZ5dWwxSXFmcTh6M0YyZGRqN2RqWE81Q0Z6VmlfOXc?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Sanara MedTech (SMTI) Is Reframing Its Growth Story Around A Steady US$34 Target", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/sanara-medtech-smti-reframing-growth-131721941.html", "source_name": "Simply Wall St.", "published_at": "2026-05-05T13:17:21+00:00", "published_display": "05 May 2026 13:17", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What Makes Sanara Medtech (SMTI) A Compelling Risk-Reward Opportunity?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPdjMwWGxDNDVZNGtQSDNkdV9KSGFiUzlOZXNEV0pjVDNJS1dBUVZ5bFNWTEt3akYzay10bDFFQUhmRFVfS2Z0ckVXb0tnbEtJQzhVeUtLNmJYakgxdmxlNDZWZURtbWlLdDF6ek16UjIyYzNVZUl6cnJxOUR4NXVFVFFXWUl1RmxqSHB5Vk1Xby1MNjUzN1RheTJ1ckNVVGtON3pz?oc=5", "source_name": "Market source", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Sanara MedTech (SMTI) Story Is Shifting With New Targets And Growth Assumptions", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQaUp4M3ZuX3B1a0xmeGtQbWlJYWRvNm9sR29SYjFjWlZ1SlA1QWdMVWtGRXhwMVlKQllPVHRWNXlwSVJjNV9BMW05YWY5ZERrTGgzbVJmSkI2OGlaNW55X2dlZjBEdHY0dlJhbW81QVBsVEs2MTVNLV9WMTNlaWdJUDRwd1dKWE9YYVQyMkFZRVFpYnRtdmI2WTlkMHRjdkJn?oc=5", "source_name": "Market source", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech Inc. (SMTI) Q4 Earnings Miss Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQX29JZW1MX0pzNmY4TzNPQmFYOXB0MktaS09UY0JzWExqOTJ5MHM4QU5jeTFHTWRTT3NLeVh6OHpiNkdBM0QxYVMzTVQtMDc3endlcjBZa2hxa05Gcm1RV2VuUzZuNVVYZENER3M2dTV6enI3MndCNHNnYVU5U0llRHRnX1RGWGJFWE5PUXFCUEJ1Q1J2UGtkeFhzMA?oc=5", "source_name": "Market source", "published_at": "2026-03-24T07:00:00+00:00", "published_display": "24 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech (SMTI) Is Down 23.5% After Q3 Loss and THP Exit \u2013 Has the Investment Case Shifted?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-13T08:00:00+00:00", "published_display": "13 Nov 2025 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech Inc. Completes Evaluation of Strategic Alternatives, Discontinues Tissue Health Plus Operations", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxQSU9XVUFuLWRmRG1ra0RzUkxEV2E0VEFoS25QM2xlSFJkMHlHak5sRG5LV3ktTmpZeG0yYlZqQXhUR0tlUjVKNl96YVF6NF9pdTA0b0NfdjZqd3dHZUI4aXdjMkFTd1VBRy1OWFl5bE1rTnNGNUVvbE1RV3RPV2otelJURnAzQkhwV0NEdng1ZGtBUEVhMUZOaTZrX01iNGYtS0NtZjNLOGNOVWtKcXNmcGtrWHRZZ0kyRTVmcHo5eTlTRDgwS25ITU9DZEY4YUNpNFlsT1ljYzBDZ1E?oc=5", "source_name": "Quiver Quantitative", "published_at": "2025-11-11T08:00:00+00:00", "published_display": "11 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The recent pullback must have dismayed Sanara MedTech Inc. (NASDAQ:SMTI) insiders who own 31% of the company", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-07-16T07:00:00+00:00", "published_display": "16 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech Inc. Announces Closing of Scendia Biologics, LLC Acquisition", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxPY2ljQnJOVUtrSGNlY243eEFXUUF4MkJidUNQWjN3SEl2TXlHeXN2OWJxVEdfU1hQMUZEY1Y0SzFUMG4zZnQ1SmNGRTVnVGo0UFpWZEh1WFJkNzZ2RzRnUWVCY1dPQ0ItVHNhZWloYWZMejlISTYyX3k1WExrLXN5UXd4QjllNXBtbjgzUmdKSDU4U3dPXzU4NE1lcGpKZGJEYTUxbjRxN1VtRzJNejJJaXcxaVpERDBzOVNxMjFic0RKdWdYdUI1dElsT2RBNk85LWozX0NSVElCcHlJRGc?oc=5", "source_name": "GlobeNewswire", "published_at": "2022-07-05T07:00:00+00:00", "published_display": "05 Jul 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sanara MedTech (SMTI) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE9qbE45TFRZaXdyQkdrcF9UMDVjdHBXanktTDNkcG1uQ3FTLVM2RTZwemlpYVl0VXZDd3NnWC1IRU45TDZ2bHAyWGFXRUNTTzF1TFJNUHpNY0hjUQ?oc=5", "source_name": "MarketBeat", "published_at": "2019-10-22T14:54:48+00:00", "published_display": "22 Oct 2019 14:54", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 84, "total_relevant": 49, "sentiment_summary": {"positive": 15, "negative": 5, "neutral": 29, "score": 54, "total": 49, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 77, "events": [{"event": "general", "label": "Market update", "weight": 13.2, "count": 24}, {"event": "earnings", "label": "Earnings", "weight": 7.7, "count": 14}, {"event": "analyst", "label": "Analyst action", "weight": 2.2, "count": 4}, {"event": "liquidity", "label": "Balance sheet", "weight": 2.0, "count": 3}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}], "positive_events": 15, "negative_events": 5}, "market_context": {"has_market_context": true, "latest_close": 23.82, "latest_week": "2026-07-10", "one_week_move": -4.1, "four_week_move": 14.5, "twelve_week_move": 14.7, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.236492, "market_dynamics_buy_signal": false, "relative_strength": -15.678417, "fair_value_gap": -21.3, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 43.8257, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-4.1% over one week, +14.5% over four weeks, trend active, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 62, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 10}, {"label": "TradingKey", "count": 7}, {"label": "Stock Titan", "count": 7}, {"label": "Market source", "count": 4}, {"label": "MarketBeat", "count": 2}, {"label": "Stock Traders Daily", "count": 2}, {"label": "dars.gov.et", "count": 2}, {"label": "Simply Wall St.", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 49}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 24}, {"label": "Earnings", "count": 14}, {"label": "Analyst action", "count": 4}, {"label": "Balance sheet", "count": 3}, {"label": "Deals and strategy", "count": 2}, {"label": "Capital return", "count": 1}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "77/100 classification confidence."}, {"label": "Company focus", "value": "49", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-4.1% over one week, +14.5% over four weeks, trend active, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Sanara MedTech Inc. (NASDAQ:SMTI) Receives Consensus Recommendation of \"Moderate Buy\" from Analysts"}], "updated_at": "2026-07-16T11:51:12.797230+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}